|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.05.26 - 12:24
|
Bulletin from Sobi′s Annual General Meeting (AGM) (PR Newswire)
|
|
|
STOCKHOLM, May 6, 2026 /PRNewswire/ -- The Swedish Orphan Biovitrum AB (publ) (Sobi®) AGM was convened today on 6 May 2026. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows: Adoption of the profit and loss statements and balance sheet and......
|
|
|
06.05.26 - 12:18
|
Bulletin from Sobi′s Annual General Meeting (AGM) (PR Newswire)
|
|
|
STOCKHOLM, May 6, 2026 /PRNewswire/ -- The Swedish Orphan Biovitrum AB (publ) (Sobi®) AGM was convened today on 6 May 2026. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows: Adoption of the profit and loss statements and balance sheet and......
|
|
|
|
|
|
|
|
|
28.04.26 - 08:27
|
Sobi Q1 2026 report: Strong execution and pipeline momentum (PR Newswire)
|
|
|
STOCKHOLM, April 28, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter of 2026. First Quarter 2026 Total revenue increased 24 per cent at CER (constant exchange rates), 11 per cent at actual rates, to SEK 7,184 M (6,465)......
|
|
|
28.04.26 - 08:24
|
Sobi Q1 2026 report: Strong execution and pipeline momentum (PR Newswire)
|
|
|
STOCKHOLM, April 28, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter of 2026. First Quarter 2026 Total revenue increased 24 per cent at CER (constant exchange rates), 11 per cent at actual rates, to SEK 7,184 M (6,465)......
|
|
|
31.03.26 - 13:06
|
Sobi publishes Annual and Sustainability Report for 2025 (PR Newswire)
|
|
|
STOCKHOLM, March 31, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today published its Annual and Sustainability report for 2025, outlining the company's progress in unlocking the potential of breakthrough innovations and therapies for people living with rare diseases.......
|
|
|
31.03.26 - 11:00
|
Sobi publishes Annual and Sustainability Report for 2025 (Cision)
|
|
|
Swedish Orphan Biovitrum AB (publ) (Sobi®) today published its Annual and Sustainability report for 2025, outlining the company's progress in unlocking the potential of breakthrough innovations and therapies for people living with rare diseases.
Sobi has a strong focus on building a sustainable business through collaboration and scientific expertise, ensuring that everyone eligible within its therapeutic areas has access to approved medicines. In 2025, over 53,000 full-time equivalent patients were treated with a Sobi medicine, delivering on Sobi's mission to deliver therapies for people...
|
|
|
|
|
18.02.26 - 09:30
|
Sobi Targets SEK 55 Bln Revenue By 2030 (AFX)
|
|
|
STOCKHOLM (dpa-AFX) - Swedish Orphan Biovitrum AB (SWOBY) on Wednesday said it is hosting its Capital Markets Day, today, where the biopharma company plans to outline a new mid-term ambition to re......
|
|
|
11.02.26 - 13:27
|
Sobi to host a Capital Markets Day on 18 February 2026 (PR Newswire)
|
|
|
STOCKHOLM, Feb. 11, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (Sobi) invites investors, analysts, and other stakeholders to its upcoming Capital Markets Day (CMD), which will be held in person in Stockholm, Sweden, on 18 February 2026, starting at 13:00 CET. A live webcast will......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
